MedTrace Logo

Immune System Function Following Vaccination in HIV Infected Children Taking Anti-HIV Drugs

NCT00257127 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 101

Last updated 2021-11-01

No results posted yet for this study

Summary

The purpose of this study is to determine immune system function following vaccination in HIV-infected children currently taking anti-HIV drugs. To test the effectiveness of prior vaccination, patients in this study will receive booster shots of one of two pneumococcal vaccines, a hepatitis B vaccine, and a measles vaccine.

Conditions

  • HIV Infections

Interventions

BIOLOGICAL

Pneumococcal 7-valent conjugate vaccine

0.5 mL administered intramuscularly

BIOLOGICAL

Pneumococcal polysaccharide vaccine

0.5 mL administered intramuscularly

BIOLOGICAL

Hepatitis B vaccine

0.5 mL administered intramuscularly

BIOLOGICAL

Measles, mumps, and rubella virus vaccine, live

0.5 mL administered subcutaneously

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • Mark Abzug, MD · The Children's Hospital, Denver, CO

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
23 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-02-28
Primary Completion
2006-08-31
Completion
2006-08-31

Countries

  • United States
  • Puerto Rico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00257127 on ClinicalTrials.gov